Ricerca Biosciences has been granted a Drug Enforcement Administration (DEA) license. The DEA license allows the company to handle multiple kilos of controlled Schedule II-V substances for R&D projects at its Concord, OH facility, including preparation of Phase I to Phase II clinical bulk API supplies. DEA licenses companies based on documented accountability of material usage and disposal, secure storage and strong ICH Q7A compliance, as well as a team of experienced chemists to execute ...